CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab. Issue 3 (June 2019) - Khan, Murtaza; Ney, Douglas E.; Kleinschmidt-DeMasters, Bette K.; Horton, Lindsay; Alvarez, Enrique; Piquet, Amanda L.